Literature DB >> 32902346

Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy.

Boudewijn J H Dierick1,2, Thys van der Molen1,2, Bertine M J Flokstra-de Blok2,3, Antonella Muraro4, Maarten J Postma5, Janwillem W H Kocks2,3, Job F M van Boven2,6.   

Abstract

INTRODUCTION: Asthma, allergic rhinitis, atopic dermatitis, and food allergy affect approximately 20% of the global population. Few studies describe the burden of the totality of these diseases and only a handful studies provide a comprehensive overview of the socioeconomic impact of these diseases. AREAS COVERED: For this narrative review, we searched Pubmed using selected keywords and inspected relevant references using a snowballing process. We provide an overview of the socioeconomic burden of allergic diseases (in particular, asthma, allergic rhinitis, atopic dermatitis, and food allergy). The focus of this review is on their epidemiology (incidence, prevalence), burden (disability-adjusted life years, quality of life), and direct and indirect costs (absenteeism and presenteeism). We have put special emphasis on differences between countries. EXPERT COMMENTARY: Both the prevalence and the burden of allergic diseases are considerable with prevalence varying between 1% and 20%. We identified a plethora of studies on asthma, but studies were generally difficult to compare due to the heterogeneity in measures used. There were only few studies on the burden of food allergy; therefore, more studies on this allergy are required. For future studies, we recommend standardizing epidemiologic, socioeconomic impact, and quality of life measures of allergic diseases.

Entities:  

Keywords:  Asthma; allergic rhinitis; atopic dermatitis; direct costs; food allergy

Mesh:

Year:  2020        PMID: 32902346     DOI: 10.1080/14737167.2020.1819793

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  29 in total

1.  Therapeutic effects of intranasal tocotrienol-rich fraction on rhinitis symptoms in platelet-activating factor induced allergic rhinitis.

Authors:  Cheryl Wei Ling Teo; Stephanie Jia Ying Png; Yee Wei Ung; Wei Ney Yap
Journal:  Allergy Asthma Clin Immunol       Date:  2022-06-13       Impact factor: 3.373

2.  White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA.

Authors:  Louise De Prins; Ulrike Raap; Tara Mueller; Peter Schmid-Grendelmeier; Christiane H Haase; Vibeke Backer; Wytske Fokkens; Linda B Benoist; Emmanuel Prokopakis; Claire Hopkins; Nele Claeys; Thijs Teeling; Lindsay Cypers; Leen Cools; Leif H Bjermer; Zuzana Diamant; Ulrich Wahn; Glenis Scadding; Claus Bachert; Sunni R Patel; Elizabeth Van Staeyen; Peter Hellings
Journal:  Front Allergy       Date:  2022-06-02

3.  Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study.

Authors:  Kazuki Fujioka; Akiko Kasahara; Takashi Kida; Wataru Fujii; Takahiro Seno; Makoto Wada; Masataka Kohno; Yutaka Kawahito
Journal:  Allergy Asthma Clin Immunol       Date:  2022-07-11       Impact factor: 3.373

Review 4.  One march, many paths: Insights into allergic march trajectories.

Authors:  Stanislaw J Gabryszewski; David A Hill
Journal:  Ann Allergy Asthma Immunol       Date:  2021-05-07       Impact factor: 6.248

Review 5.  Monoclonal Antibodies and Airway Diseases.

Authors:  Annina Lyly; Anu Laulajainen-Hongisto; Philippe Gevaert; Paula Kauppi; Sanna Toppila-Salmi
Journal:  Int J Mol Sci       Date:  2020-12-13       Impact factor: 5.923

6.  Respiratory Adherence Care Enhancer Questionnaire: Identifying Self-Management Barriers of Inhalation Corticosteroids in Asthma.

Authors:  Claire D Visser; Jip M Linthorst; Esther Kuipers; Jacob K Sont; Joyca P W Lacroix; Henk-Jan Guchelaar; Martina Teichert
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

7.  Impact of house dust mite-driven asthma on children's school performance and activity.

Authors:  Catalina Gómez; Judit Barrena; Vanesa García-Paz; Ana M Plaza; Paula Crespo; José A Bejarano; Ana B Rodríguez; Laia Ferré; Lidia Farrarons; Marta Viñas; Carla Torán-Barona; Andrea Pereiro; José L Justicia; Santiago Nevot
Journal:  Eur J Pediatr       Date:  2021-12-21       Impact factor: 3.183

8.  Bioinformatic Analysis and Cellular Assays Identify Substance P Influencing Th17/Treg Differentiation via the MyD88 Pathway as a Potential Contributor to the Progression of Asthma and Allergic Rhinitis.

Authors:  Yuemei Ma; Chang Liu; Guangpeng Xi; Yuanyuan Guan; Yao Tang; Jing Zhang; Yue Xu
Journal:  Dis Markers       Date:  2022-02-12       Impact factor: 3.434

Review 9.  Recent Advances in the Inhibition of the IL-4 Cytokine Pathway for the Treatment of Allergen-Induced Asthma.

Authors:  Oliver Massey; Cenk Suphioglu
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

10.  S100A4 Is Critical for a Mouse Model of Allergic Asthma by Impacting Mast Cell Activation.

Authors:  Tongqian Wu; Lan Ma; Xiaoqian Jin; Jingjing He; Ke Chen; Dingshan Zhang; Rui Yuan; Jun Yang; Qin Zhong; Haiyan Zhou; Zou Xiang; Yu Fang
Journal:  Front Immunol       Date:  2021-07-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.